Monte Rosa Therapeutics, Inc. (GLUE)

Monte Rosa Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	69.43	224.25	128.1	54.91	346.07	41.7
Short-Term Investments	221.17	147.9	104.31	207.91	-	-
Cash & Short-Term Investments	290.59	372.15	232.41	262.83	346.07	41.7
Cash Growth	10.83%	60.12%	-11.57%	-24.05%	729.93%	595.56%
Other Receivables	2.37	0.17	0.51	7.66	-	0.1
Receivables	2.37	0.17	0.51	7.66	-	0.1
Prepaid Expenses	6.5	5.12	3.29	4.44	2.6	1.79
Restricted Cash	-	-	-	0.96	-	-
Total Current Assets	299.47	377.44	236.21	275.89	348.67	43.59
Property, Plant & Equipment	54.73	56.31	62.61	61.91	12.33	4.62
Other Long-Term Assets	5.4	4.98	4.93	4.6	5.34	1.16
Total Assets	359.59	438.73	303.76	342.39	366.33	49.38
Accounts Payable	5.58	17.22	11.15	7.86	6.56	7.07
Accrued Expenses	12.26	15.43	12.93	9.56	9.24	1.13
Current Portion of Leases	4.09	3.71	3.16	3.13	-	-
Current Unearned Revenue	18.41	117.23	17.68	-	-	-
Other Current Liabilities	1.51	3.35	1.67	5.02	0.84	21.08
Total Current Liabilities	41.85	156.95	46.59	25.57	16.64	29.28
Long-Term Leases	37.04	39	42.88	43.87	-	-
Long-Term Unearned Revenue	8.06	16.15	32.32	-	-	-
Pension & Post-Retirement Benefits	4.56	3.7	2.71	1.53	2.18	1.07
Total Liabilities	91.51	215.8	124.51	70.98	18.81	30.34
Common Stock	0.01	0.01	0.01	0.01	0.01	0
Additional Paid-In Capital	675.45	664.87	547.86	503.7	471.57	0.4
Retained Earnings	-404	-438.59	-365.89	-230.54	-122.04	-48.08
Comprehensive Income & Other	-3.37	-3.36	-2.72	-1.75	-2.02	-1.06
Total Common Equity	268.08	222.94	179.25	271.41	347.52	-48.73
Shareholders' Equity	268.08	222.94	179.25	271.41	347.52	19.04
Total Liabilities & Equity	359.59	438.73	303.76	342.39	366.33	49.38
Total Debt	41.13	42.72	46.04	47	-	-
Net Cash (Debt)	249.46	329.43	186.37	215.83	346.07	41.7
Net Cash Growth	14.51%	76.76%	-13.65%	-37.64%	729.93%	695.02%
Net Cash Per Share	3.02	4.46	3.63	4.57	13.84	27.49
Filing Date Shares Outstanding	61.76	61.51	50.14	49.24	46.37	1.69
Total Common Shares Outstanding	61.72	61.51	50.14	49.32	46.54	1.69
Working Capital	257.61	220.49	189.62	250.32	332.03	14.32
Book Value Per Share	4.34	3.62	3.57	5.50	7.47	-28.91
Tangible Book Value	268.08	222.94	179.25	271.41	347.52	-48.73
Tangible Book Value Per Share	4.34	3.62	3.57	5.50	7.47	-28.91
Machinery	28.59	27.4	24.23	18.65	13.06	5.23
Construction In Progress	1.18	0.06	0.92	12.01	0.85	-
Leasehold Improvements	22.71	22.39	20.89	2.66	1.12	-

Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q